S. Richman
Jun 10, 1974
Citations
0
Influential Citations
40
Citations
Journal
JAMA
Abstract
Intravenously administered atropine sulfate is commonly used for the control of bradycardias during myocardial infarction. There is increasing evidence that this may not be beneficial to the patient and that serious arrhythmias may be produced. Atropine has also been demonstrated to increase the area of ischemia during myocardial infarction in dogs, but this has not been well documented in humans. It is suggested that atropine be used cautiously during myocardial infarction, and only when the hemodynamic situation clearly warrants its use or when a serious cardiac arrhythmia exists. ( JAMA 228:1414-1416, 1974)